YOLFTbeta
Shanghai ZJ Bio-Tech Co. Ltd. A

Shanghai ZJ Bio-Tech Co. Ltd. A

688317 · SHG · Healthcare / Medical Devices

15.94CNY-0.62 (-3.74%)

Price History

Full chart

Market Stats

Previous Close16.56
Open16.49
Day Range15.88 – 16.71
52-Week Range14.64 – 28.58
Volume1.54M
Market Cap3.70B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.37
Dividend Yield0.00%
Beta0.62
50-Day Avg17.05
200-Day Avg19.02

About

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Junbin Shao
  • Employees269
  • HeadquartersPujiang Wisdom Plaza, Shanghai, China, 201114, China
  • Websitehttps://www.liferiver.com.cn

Leadership

  • Mr. Junbin ShaoChairman, GM & Dean of Research Institute · b. 1971
  • Ms. Weiqin NiDeputy GM, Secretary, Acting CFO & Director · b. 1981
  • Mr. Kai WangDeputy General Manager · b. 1982

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue84.27M101.04M126.68M156.64M192.71M224.35M258.87M2.05B2.02B2.33B274.33M178.65M124.91M
Growth (%)-+19.89%+25.38%+23.65%+23.03%+16.42%+15.39%+692.72%-1.62%+15.23%-88.21%-34.88%-30.08%
Cost of Revenue17.43M19.52M23.16M27.50M35.26M43.53M61.84M535.62M762.40M1.13B282.13M216.07M44.74M
Gross Profit66.84M81.51M103.52M129.14M157.45M180.82M197.03M1.52B1.26B1.20B-7.80M-37.42M124.91M
Gross Margin79.31%80.68%81.72%82.44%81.70%80.60%76.11%73.90%62.24%51.40%-2.84%-20.95%100.00%
Operating Expense34.37M44.96M64.59M77.91M95.49M108.21M135.73M404.86M355.30M288.25M141.70M108.25M173.26M
Operating Income32.46M36.55M38.93M51.22M61.96M72.61M61.31M1.11B901.12M907.36M-149.50M-145.67M-48.35M
Operating Margin38.52%36.18%30.73%32.70%32.15%32.37%23.68%54.17%44.64%39.01%-54.50%-81.54%-38.71%
EBITDA42.66M50.31M51.15M73.75M81.12M94.72M83.84M1.13B922.10M958.98M-92.61M-84.54M22.77M
EBITDA Margin50.62%49.79%40.37%47.08%42.10%42.22%32.39%55.02%45.67%41.22%-33.76%-47.32%18.23%
Net Income29.57M34.99M32.52M48.74M51.53M62.32M51.52M932.01M758.52M760.27M-136.86M-127.46M-34.30M
Net Income Margin35.09%34.63%25.67%31.11%26.74%27.78%19.90%45.42%37.57%32.68%-49.89%-71.35%-27.46%
R&D9.16M-17.96M19.14M20.10M19.92M23.40M52.43M108.79M104.62M61.00M58.78M50.87M
R&D as % of Total Revenue10.87%-14.18%12.22%10.43%8.88%9.04%2.55%5.39%4.50%22.24%32.90%40.72%
Interest Expense1.21M1.00M2.07M-175.21K105.89K96.50K256.40K886.69K463.69K572.54K344.33K3.49M
Interest Expense % of Total Revenue1.43%0.99%1.64%-0.09%0.05%0.04%0.01%0.04%0.02%0.21%0.19%2.79%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets169.78M199.63M394.29M526.57M516.12M579.64M641.93M1.88B4.25B4.74B4.07B3.79B3.76B
Total Liabilities51.75M89.28M50.82M42.66M43.42M46.98M70.09M416.97M427.27M543.44M249.25M153.06M414.95M
Total Equity117.85M110.18M343.31M483.76M472.70M532.66M571.84M1.46B3.83B4.20B3.82B3.64B3.35B
Cash24.50M28.29M96.83M96.68M207.87M266.04M246.09M1.20B2.94B3.15B2.77B2.78B2.55B
Total Debt14.61M11.31M3.61M------8.63M7.45M4.93M-
Net Debt-9.89M-16.98M-93.22M-96.68M-207.87M-266.04M-246.09M-1.20B-2.94B-3.14B-2.76B-2.78B-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow28.16M27.57M12.78M44.53M48.00M80.63M76.66M1.14B641.94M584.97M-81.88M77.59M66.85M
Investing Cash Flow-17.79M-18.99M-93.68M-128.66M127.80M-24.48M-31.56M-86.30M-519.06M-76.02M-77.69M-19.42M-
Financing Cash Flow-4.76M-4.75M149.91M81.41M-62.48M-189.51K-65.71M-68.50M1.63B-371.40M-234.39M-58.72M-
Capital Expenditure13.72M21.83M23.68M31.82M28.65M17.48M23.56M74.58M498.06M74.56M81.15M19.49M1.99M
Free Cash Flow14.44M5.74M-10.91M12.70M19.36M63.15M53.10M1.07B143.88M510.41M-163.03M58.10M64.86M
Dividends Paid1.22M955.93K42.11M45.02M58.41M189.51K65.71M65.71M311.53M265.62M230.74M20.88M3.03M
FCF to OCF51.26%20.81%-85.38%28.53%40.32%78.32%69.27%93.47%22.41%87.25%199.10%74.89%97.02%
Dividend Paid to FCF8.44%16.66%-386.02%354.47%301.78%0.30%123.74%6.16%216.52%52.04%-141.53%35.94%4.68%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Sep 9, 2022Nov 28, 2022Dec 31, 2022Apr 26, 2023
EPS Estimate---------
EPS Actual1.620.361.110.801.411.040.780.690.03
Surprise---------
Timing-----Pre-marketPre-market-After-hours

Key Statistics & Ratios

Market Cap3.70B
Enterprise Value1.18B
Trailing P/E0.00
Forward P/E0.00
Price / Sales31.23
Price / Book1.13
EPS-0.37
Book Value18.82
Revenue (TTM)118.52M
Gross Profit (TTM)87.65M
EBITDA-23.58M
Profit Margin-54.87%
Operating Margin-66.83%
Return on Equity-1.94%
Return on Assets-1.46%
Shares Outstanding189.84M
Shares Float98.06M
Beta0.62
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20241×
0.11Oct 18, 2024
20231×
1.20Jun 14, 2023
20221×
1.36May 27, 2022
20211×
1.60Jun 8, 2021